143 related articles for article (PubMed ID: 38740443)
1. Coexisting presentation of two rare genetic variants of autosomal dominant polycystic kidney disease and Alport syndrome.
Venda J; Henriques A; Leal R; Alves R
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38740443
[TBL] [Abstract][Full Text] [Related]
2. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous adult polycystic kidney disease and Alport syndrome.
Phelan PJ; Fletcher E; Carroll N; Metcalfe W; Turner AN
Nephrology (Carlton); 2016 Aug; 21(8):722-3. PubMed ID: 27436620
[No Abstract] [Full Text] [Related]
4. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
5. Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.
Petzold F; Bachmann A; Bergmann C; Helmchen U; Halbritter J
BMC Nephrol; 2019 Sep; 20(1):340. PubMed ID: 31477057
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.
Furlano M; Martínez V; Pybus M; Arce Y; Crespí J; Venegas MDP; Bullich G; Domingo A; Ayasreh N; Benito S; Lorente L; Ruíz P; Gonzalez VL; Arlandis R; Cabello E; Torres F; Guirado L; Ars E; Torra R
Am J Kidney Dis; 2021 Oct; 78(4):560-570.e1. PubMed ID: 33838161
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.
Gibson JT; Huang M; Shenelli Croos Dabrera M; Shukla K; Rothe H; Hilbert P; Deltas C; Storey H; Lipska-Ziętkiewicz BS; Chan MMY; Sadeghi-Alavijeh O; Gale DP; ; Cerkauskaite A; Savige J
Sci Rep; 2022 Feb; 12(1):2722. PubMed ID: 35177655
[TBL] [Abstract][Full Text] [Related]
8. Genetic diagnosis of polycystic kidney disease, Alport syndrome, and thalassemia minor in a large Chinese family.
Miao Y; Xiong J; Zhang X; Huang H; Yu L; Chen J; Deng W; Xu H; Liu R; Xiang C; Xu X; Xiong F
Clin Sci (Lond); 2017 Oct; 131(19):2427-2438. PubMed ID: 28827396
[TBL] [Abstract][Full Text] [Related]
9. A Novel
Graziani L; Minotti C; Carriero ML; Bengala M; Lai S; Terracciano A; Novelli A; Novelli G
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790225
[TBL] [Abstract][Full Text] [Related]
10. A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
Rosado C; Bueno E; Fraile P; García-Cosmes P; González-Sarmiento R
Eur J Med Genet; 2015 Jan; 58(1):35-8. PubMed ID: 25450602
[TBL] [Abstract][Full Text] [Related]
11. Pseudodominant Alport syndrome caused by pathogenic homozygous and compound heterozygous COL4A3 splicing variants.
Mohamed M; Tellez J; Bergmann C; Gale DP; Sayer JA; Olinger E
Ann Hum Genet; 2022 May; 86(3):145-152. PubMed ID: 34888854
[TBL] [Abstract][Full Text] [Related]
12. COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.
Storey H; Savige J; Sivakumar V; Abbs S; Flinter FA
J Am Soc Nephrol; 2013 Dec; 24(12):1945-54. PubMed ID: 24052634
[TBL] [Abstract][Full Text] [Related]
13. Women and Alport syndrome.
Rheault MN
Pediatr Nephrol; 2012 Jan; 27(1):41-6. PubMed ID: 21380623
[TBL] [Abstract][Full Text] [Related]
14. Alport Syndrome: Achieving Early Diagnosis and Treatment.
Kashtan CE
Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant Alport syndrome due to a COL4A4 mutation with an additional ESPN variant detected by whole-exome analysis.
Izumi Y; Hamaguchi A; Miura R; Nakagawa T; Nakagawa M; Saida K; Miyake N; Nagayoshi Y; Kakizoe Y; Miyoshi T; Kohda Y; Misumi Y; Matsumoto N; Ando Y; Mukoyama M
CEN Case Rep; 2020 Feb; 9(1):59-64. PubMed ID: 31677115
[TBL] [Abstract][Full Text] [Related]
16. Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.
Temme J; Peters F; Lange K; Pirson Y; Heidet L; Torra R; Grunfeld JP; Weber M; Licht C; Müller GA; Gross O
Kidney Int; 2012 Apr; 81(8):779-83. PubMed ID: 22237748
[TBL] [Abstract][Full Text] [Related]
17. Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
Zhang Y; Ding J
Pediatr Nephrol; 2018 Aug; 33(8):1309-1316. PubMed ID: 28864840
[TBL] [Abstract][Full Text] [Related]
18. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
[TBL] [Abstract][Full Text] [Related]
19. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
20. Digenic Alport Syndrome.
Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
